ID SYI_BIFLO Reviewed; 1103 AA. AC Q8G3I2; DT 20-DEC-2005, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2003, sequence version 1. DT 27-MAR-2024, entry version 113. DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02003}; DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02003}; DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02003}; DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02003}; GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02003}; OrderedLocusNames=BL1777; OS Bifidobacterium longum (strain NCC 2705). OC Bacteria; Actinomycetota; Actinomycetes; Bifidobacteriales; OC Bifidobacteriaceae; Bifidobacterium. OX NCBI_TaxID=206672; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=NCC 2705; RX PubMed=12381787; DOI=10.1073/pnas.212527599; RA Schell M.A., Karmirantzou M., Snel B., Vilanova D., Berger B., Pessi G., RA Zwahlen M.-C., Desiere F., Bork P., Delley M., Pridmore R.D., Arigoni F.; RT "The genome sequence of Bifidobacterium longum reflects its adaptation to RT the human gastrointestinal tract."; RL Proc. Natl. Acad. Sci. U.S.A. 99:14422-14427(2002). CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS CC can inadvertently accommodate and process structurally similar amino CC acids such as valine, to avoid such errors it has two additional CC distinct tRNA(Ile)-dependent editing activities. One activity is CC designated as 'pretransfer' editing and involves the hydrolysis of CC activated Val-AMP. The other activity is designated 'posttransfer' CC editing and involves deacylation of mischarged Val-tRNA(Ile). CC {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L- CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666, CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528, CC ChEBI:CHEBI:456215; EC=6.1.1.5; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02003}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02003}; CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and CC one for editing. The misactivated valine is translocated from the CC active site to the editing site, which sterically excludes the CC correctly activated isoleucine. The single editing site contains two CC valyl binding pockets, one specific for each substrate (Val-AMP or Val- CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family. CC IleS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02003}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AE014295; AAN25560.1; -; Genomic_DNA. DR RefSeq; NP_696924.1; NC_004307.2. DR RefSeq; WP_011068832.1; NC_004307.2. DR AlphaFoldDB; Q8G3I2; -. DR SMR; Q8G3I2; -. DR STRING; 206672.BL1777; -. DR EnsemblBacteria; AAN25560; AAN25560; BL1777. DR KEGG; blo:BL1777; -. DR PATRIC; fig|206672.9.peg.1832; -. DR HOGENOM; CLU_001493_1_1_11; -. DR OrthoDB; 9810365at2; -. DR PhylomeDB; Q8G3I2; -. DR Proteomes; UP000000439; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule. DR GO; GO:0000049; F:tRNA binding; IEA:InterPro. DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule. DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1. DR CDD; cd00818; IleRS_core; 1. DR Gene3D; 3.40.50.620; HUPs; 2. DR Gene3D; 3.90.740.10; Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain; 1. DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1. DR InterPro; IPR001412; aa-tRNA-synth_I_CS. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR033709; Anticodon_Ile_ABEc. DR InterPro; IPR002301; Ile-tRNA-ligase. DR InterPro; IPR023586; Ile-tRNA-ligase_type2. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR NCBIfam; TIGR00392; ileS; 1. DR PANTHER; PTHR42780:SF1; ISOLEUCINE--TRNA LIGASE, CYTOPLASMIC; 1. DR PANTHER; PTHR42780; SOLEUCYL-TRNA SYNTHETASE; 1. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF19302; DUF5915; 1. DR Pfam; PF00133; tRNA-synt_1; 1. DR PRINTS; PR00984; TRNASYNTHILE. DR SUPFAM; SSF47323; Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases; 1. DR SUPFAM; SSF52374; Nucleotidylyl transferase; 1. DR SUPFAM; SSF50677; ValRS/IleRS/LeuRS editing domain; 1. DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1. PE 3: Inferred from homology; KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding; KW Nucleotide-binding; Protein biosynthesis; Reference proteome; Zinc. FT CHAIN 1..1103 FT /note="Isoleucine--tRNA ligase" FT /id="PRO_0000098524" FT REGION 1..25 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 65..75 FT /note="'HIGH' region" FT MOTIF 649..653 FT /note="'KMSKS' region" FT BINDING 652 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02003" SQ SEQUENCE 1103 AA; 124066 MW; B09FBEA401C18C28 CRC64; MSENVYPKAN EGGETAHVAP NPSFPDMEET VLDYWDKDDT FQKSVERNPS GDHSQNEFVF FDGPPFANGL PHYGHLLTGY AKDVIPRYQT MKGRKVNRVF GWDTHGLPAE LEAQKELGID SVDQIEKMGI DKFNDACRAS VLKYTNEWQN YVHRQARWVD FEHGYKTLNI PYMESVMWAF KQLYDKGLAY QGYRVLPYCP KDRTPLSAHE LRMDADVYQD RQDTTVSVAV KMRDEDDAYA VFWTTTPWTV PTNFAIVVGG DIDYVEVRPT EGKFAGKKFY LGKDLLPHYE KELGENYEVV RELKGSELEG RRYYPVFPYF AGDEAESEGH VPGPNGYTIF TADYVDTVEG TGLVHQAPYG EDDMNTLNAK GIKSTDVLDD GCRFTAQCPD YEGDFVFDAN LPILRNLRAG DGPLAEIPEE RRAILFQEKS YVHSYPHCWR CATPLIYKPV SSWFVSVTKI KPRLLELNQQ INWIPGNVKD GQFGKWLANA RDWSISRNRF WGSPIPVWVS DDPKYPRVDV YGSLEELKAD FGDYPRDKDG NINMHRPWID NLVRVNPDDP TGKSHMHRIS DVLDCWFESG SMSFAQFHYP FENKEKFEQH FPADYIVEYI GQTRGWFYLL HVMATALFDR PAFKNVICHG IVLGSDGQKM SKHLRNYPDV NGVFDKYGSD AMRWFLMSSP ILRGGNLIVT ADGIRDTVRQ VMLPVWSSYY FFTLYANAAN GGAGFDARQL RADEVAGLPE MDRYLLARTR RLVLAAEKSL NEFAISDACD AVSDFIDVLT NWYIRNTRDR FWNEDASAFN TLYTVLEAFM RVLAPLAPME AESVWRGLTG GESVHLAEWP FVVDEKTGAD TELGRVLVDD PALVDAMEKV REVVSGTLSL RKAAKIRVRQ PLSKLTVVAG NVEAVKAYDD LLKAELNIKN IEFSTLQDAA AHGLKIVHEL RVNARAAGPR LGKQVQFAIK ASKSGDWHVD AASGAPVVST PSGDLALVEG EYELINRVEE ENATEAAASV SAALPTGGFV ILDTALDADL LAEGYARDVI RSVQDARKAA DLDIADRISL VLTVPAVDVA KVEQFRDLIA HETLATSFEV KEGAELGVEV VKA //